The risk of major osteoporotic fractures with GLP-1 receptor agonists when compared to DPP-4 inhibitors: A Danish nationwide cohort study

BACKGROUND: Type 2 diabetes mellitus (T2D) is associated with an increased fracture risk. There is little evidence for the effects of glucagon-like peptide 1 receptor agonists (GLP-1RA) on fracture risk in T2D. We aimed to investigate the risk of major osteoporotic fractures (MOF) for treatment with...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Mashhadi, Zheer Kejlberg, Viggers, Rikke, Fuglsang-Nielsen, Rasmus, Vestergaard, Peter, Gregersen, Søren, Starup-Linde, Jakob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589410/
https://www.ncbi.nlm.nih.gov/pubmed/36299454
http://dx.doi.org/10.3389/fendo.2022.882998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589410/
https://www.ncbi.nlm.nih.gov/pubmed/36299454
http://dx.doi.org/10.3389/fendo.2022.882998

Ejemplares similares